Cannabinoid Receptor 1/miR-30b-5p Axis Governs Macrophage NLRP3 Expression and Inflammasome Activation in Liver Inflammatory Disease
Cannabinoid Receptor 1/miR-30b-5p Axis Governs Macrophage NLRP3 Expression and Inflammasome Activation in Liver Inflammatory Disease
复制标题
大麻素受体 1/miR-30b-5p 轴控制肝脏炎症性疾病中巨噬细胞 NLRP3 表达和炎症小体激活
DOI:
10.1016/j.omtn.2020.04.010
复制
发表时间:
2020-04
期刊:
影响因子:
--
通讯作者:
Li Liying
中科院分区:
文献类型:
--
作者:
Yang Le;Tian Lei;Zhang Zhi;Zhou Xuan;Ji Xiaofang;Liu Fuquan;Dong Chengbin;Hou Lei;Zhao Xinhao;Chang Na;Yang Lin;Li Liying
Nod-like receptor (NLR) family pyrin domain containing 3 (NLRP3) has been regarded as an important initiator or promoter in multiple inflammatory diseases. However, the relationship between cannabinoid receptor 1 (CB1) and macrophage NLRP3 inflammasome and the corresponding molecular mechanism in liver inflammation remain unclear. Mouse liver injury models were induced by carbon tetrachloride (CCl4) or methionine-choline-deficient and high fat (MCDHF) diet. Human liver tissues were obtained from patients with different chronic liver diseases. CB1 expression was increased in liver tissue and macrophages of CCl4- and MCDHF-treated mice, positively correlated with NLRP3. CB1 agonist ACEA (Arachiodonyl-2'-Chloroethylamide) promoted NLRP3 expression and NLRP3 inflammasome activation in macrophages. CB1 blockade with its antagonist AM281 reduced NLRP3 expression, inflammasome activation, and liver inflammation in CCl4- and MCDHF-treated mice. MicroRNA-30b-5p (miR-30b-5p), screened by the intersection of bioinformatics databases and downregulated miRNAs in injured liver, negatively correlated with NLRP3 in mouse and human liver. miR-30b-5p was involved in CB1-mediated activation of NLRP3 inflammasome in macrophages by directly targeting NLRP3. Importantly, administration of miR-30b-5p agomir targeted NLRP3 and attenuated liver inflammation in the injured liver. Altogether, CB1/miR-30b-5p axis modulates NLRP3 expression and NLPR3 inflammasome activation in macrophages during liver inflammation, which provides a potential target for liver disease.
登录
查看更多内容
影响因子:
25.7
作者:
Li, Changyong;Kong, Yaxian;Li, Liying
通讯作者:
Li, Liying
影响因子:
24.5
作者:
A. Mallat;S. Lotersztajn
通讯作者:
A. Mallat;S. Lotersztajn
DOI:
10.1016/j.omtn.2017.06.005
发表时间:
2017-09-15
期刊:
Molecular therapy. Nucleic acids
影响因子:
--
作者:
Chakraborty C;Sharma AR;Sharma G;Doss CGP;Lee SS
通讯作者:
Lee SS
影响因子:
24.5
作者:
Suk KT;Mederacke I;Gwak GY;Cho SW;Adeyemi A;Friedman R;Schwabe RF
通讯作者:
Schwabe RF
影响因子:
13.5
作者:
Wree, Alexander;Eguchi, Akiko;McGeough, Matthew D.;Pena, Carla A.;Johnson, Casey D.;Canbay, Ali;Hoffman, Hal M.;Feldstein, Ariel E.
通讯作者:
Feldstein, Ariel E.